Search Results - "Kamat, AM"

Chemoprevention of urological cancer by Kamat, A M, Lamm, D L

“…Cancer is a major cause of mortality and morbidity throughout the world, and ranks as the second leading cause of death in the United States. Most cancers have…”
Get more information

Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy by Kamat, Ashish M, Babaian, Kara, Cheung, Min Rex, Naya, Yoshio, Huang, Samuel H, Kuban, Deborah, Babaian, Richard J

“…Radical prostatectomy (RP) is a highly effective treatment for patients with prostate cancer. However, patients with positive surgical margins after radical…”
Get more information

Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer by Kamat, Ashish M, DeHaven, Jean I, Lamm, Donald L

“…Objectives. Despite complete transurethral resection of superficial bladder tumors, the recurrence rate averages 88% at 15 years. Intravesical chemotherapy…”
Get full text

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics? by Vlahou, Antonia, Hallinan, Dara, Apweiler, Rolf, Argiles, Angel, Beige, Joachim, Benigni, Ariela, Bischoff, Rainer, Black, Peter C., Boehm, Franziska, Céraline, Jocelyn, Chrousos, George P., Delles, Christian, Evenepoel, Pieter, Fridolin, Ivo, Glorieux, Griet, van Gool, Alain J., Heidegger, Isabel, Ioannidis, John P.A., Jankowski, Joachim, Jankowski, Vera, Jeronimo, Carmen, Kamat, Ashish M., Masereeuw, Rosalinde, Mayer, Gert, Mischak, Harald, Ortiz, Alberto, Remuzzi, Giuseppe, Rossing, Peter, Schanstra, Joost P., Schmitz-Dräger, Bernd J., Spasovski, Goce, Staessen, Jan A., Stamatialis, Dimitrios, Stenvinkel, Peter, Wanner, Christoph, Williams, Stephen B., Zannad, Faiez, Zoccali, Carmine, Vanholder, Raymond

“…The General Data Protection Regulation (GDPR) became binding law in the European Union Member States in 2018, as a step toward harmonizing personal data…”
Get full text

Clinical Outcomes of cT1 Micropapillary Bladder Cancer by Willis, Daniel L, Fernandez, Mario I, Dickstein, Rian J, Parikh, Sahil, Shah, Jay B, Pisters, Louis L, Guo, Charles C, Henderson, Samuel, Czerniak, Bogdan A, Grossman, H. Barton, Dinney, Colin P, Kamat, Ashish M

“…Purpose While many urologists recommend radical cystectomy for micropapillary bladder cancer invading the lamina propria (cT1), contradictory small reports…”
Get full text

Restaging Transurethral Resection of HG Ta Bladder Tumors: A Risk-Adapted Approach by Hensley, PJ, Bree, K, Brooks, N, Matulay, J, Nagaraju, S, Navai, N, Grossman, HB, Dinney, CP, Kamat, AM

“…The AUA and EAU Guidelines recommend patients with high grade (HG) Ta bladder tumors undergo restaging transurethral resection (reTUR) if categorized as ‘High…”
Get full text

Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin by Bree, KK, Hensley, PJ, Brooks, N, Matulay, J, Navai, N, Grossman, HB, Matin, SF, Dinney, CP, Kamat, AM

“…There is a paucity of information regarding impact of upper tract urothelial carcinoma (UTUC) on the patterns of BCG response in patients with NMIBC treated…”
Get full text

Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care by Bagheri, I, Shan, Y, Klaassen, Z, Kamat, AM, Konety, B, Mehta, HB, Baillargeon, JG, Srinivas, S, Tyler, DS, Swanson, TA, Kaul, S, Hollenbeck, BK, Williams, SB

“…Prior studies noted substantial costs associated with radical cystectomy, however, they lack surgical comparison to a less costly partial cystectomy. We…”
Get full text

Correlation between BMI, Diabetes Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer by Brooks, NA, Matulay, JT, Li, R, Kokorovic, A, Grossman, HB, Shen, Y, Gao, JJ, Navai, N, Dinney, CPN, Kamat, AM

“…The association of body mass index (BMI) and diabetes mellitus (DM) with clinical outcomes for patients with solid malignancies including bladder cancer…”
Get full text

Use of Psychotropic Drugs Among Bladder Cancer Patients in the United States by Jazzar, U, Shan, Y, Bergerot, CD, Wallis, CJD, Freedland, SJ, Kamat, AM, Tyler, DS, Baillargeon, Kuo, YF, Klaassen, Z, Williams, SB

“…Bladder cancer patients are at increased risk of physical and emotional distress, however, prescription utilization patterns largely remain to be elucidated…”
Get full text

Does liposomal bupivacaine use intraoperatively decrease postoperative narcotic use in radical cystectomy patients? by Kukreja, Janet Baack, Chang, Courtney M, Seif, Mohamed, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 311 Background: Bupivacaine liposome injectable suspension (LB) can be used to help control postoperative pain. It slowly releases bupivacaine…”
Get full text

Focus on bladder cancer by Dinney, Colin P.N., McConkey, David J., Millikan, Randall E., Wu, Xifeng, Bar-Eli, Menashe, Adam, Liana, Kamat, Ashish M., Siefker-Radtke, Arlene O., Tuziak, Tomasz, Sabichi, Anita L., Grossman, H.Barton, Benedict, William F., Czerniak, Bogdan

Get full text

The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma by Kamat, Ashish M, Gee, Jason R, Dinney, Colin P N, Grossman, H Barton, Swanson, David A, Millikan, Randall E, Detry, Michelle A, Robinson, Tracy L, Pisters, Louis L

“…Micropapillary bladder carcinoma is a rare variant of UC. Due to paucity of data regarding treatment outcomes, patients with nonmuscle invasive micropapillary…”
Get more information

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients by Williams, Stephen B., Kamat, Ashish M., Chamie, Karim, Froehner, Michael, Wirth, Manfred P., Wiklund, Peter N., Black, Peter C., Steinberg, Gary D., Boorjian, Stephen A., Daneshmand, Sia, Goebell, Peter J., Pohar, Kamal S., Shariat, Shahrokh F., Thalmann, George N.

“…Radical cystectomy continues to be associated with a significant risk of morbidity and all-cause mortality (ACM). Practice pattern data demonstrating underuse…”
Get full text

Inhibition of bladder tumor growth by 1,1-bis(3/-indolyl)-1-(p-substitutedphenyl)methanes : A new class of peroxisome proliferator-activated receptor γ agonists by KASSOUF, Wassim, CHINTHARLAPALLI, Sudhakar, ABDELRAHIM, Maen, NELKIN, Gina, SAFE, Stephen, KAMAT, Ashish M

“…1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes containing p-trifluoromethyl (DIM-C-pPhCF3), p-t-butyl (DIM-C-pPhtBu), and phenyl (DIM-C-pPhC6H5)…”
Get full text

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome by Canfield, Steven E, Kamat, Ashish M, Sánchez-Ortiz, Ricardo F, Detry, Michelle, Swanson, David A, Wood, Christopher G

“…Nodal disease in the setting of metastatic renal cell carcinoma is associated with poor prognosis. However, to our knowledge the biology of nodal metastases in…”
Get more information

A Phase II Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine, followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results by Siefker-Radtke, AO, Dinney, CP, Shen, Y, Williams, DL, Kamat, AM, Grossman, HB, Millikan, RE

Get full text

Upper urinary tract tumors with nontransitional histology: A single-center experience by Busby, J. Erik, Brown, Gordon A., Tamboli, Pheroze, Kamat, Ashish M., Dinney, Colin P.N., Grossman, H. Barton, Matin, Surena F.

“…To review our experience with patients with upper urinary tract tumors of nonurothelial origin. Upper urinary tract tumors of nonurothelial origin are uncommon…”
Get full text

Atorvastatin: A potential chemopreventive agent in bladder cancer by Kamat, Ashish M., Nelkin, Gina M.

“…To evaluate a commonly used 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor—atorvastatin—for potential activity against human bladder…”
Get full text

Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis by Jinesh, GG, Molina, JR, Huang, L, Laing, NM, Mills, GB, Bar-Eli, M, Kamat, AM

“…Apoptosis culminates in secondary necrosis due to lack of ATP. Cancer stem cells form spheres after apoptosis by evoking the blebbishield emergency program…”
Get full text